Pasithea Therapeutics Corp. · NASDAQ:KTTA
Ameriprise Financial Inc reported a 8.40% stake in Pasithea Therapeutics Corp. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Ameriprise Financial Inc reported a 8.40% stake in Pasithea Therapeutics Corp., 1,930,128 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 8.40%
- Shares
- 1,930,128
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ameriprise Financial, Inc. | 8.40% | 1,930,128 |
| Columbia Management Investment Advisers, LLC | 8.40% | 1,930,128 |
Source
Related
- Pasithea Therapeutics Corp.
- Ameriprise Financial Inc
- Pasithea Therapeutics Corp. shareholders
- Schedule 13G/A · Ameriprise Financial Inc · May 15, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Opaleye Management Inc. · Jul 31, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 23, 2026
- Form 4 · Coastlands Capital LP · Jun 22, 2026